Showing 2 posts of 2 posts found.
IBM has revealed it is to join forces with clinical laboratory service provider Quest Diagnostics in a bid to utilise …
Quest Diagnostics has begun selling a genetic test to uncover the risk of hereditary breast cancer, after the US Supreme …
PinPoint signs laboratory partnership to expand access to AI cancer risk test
NHS expands community ear and hearing pathway across 10 ICBs
London secures major investment to accelerate healthcare innovation
People with severe mental illness more likely to die early from cardiovascular disease, report finds
Yourgene wins Australian approval for chemotherapy toxicity screening assay